Published in
American Society for Microbiology, Journal of Virology, 21(95), 2021
DOI: 10.1128/jvi.00975-21
Links
Tools
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
Journal article published in 2021 by
Alex J. B. Kreutzberger 
,
Anwesha Sanyal,
Ravi Ojha ,
Jesse D. Pyle ,
Olli Vapalahti ,
Giuseppe Balistreri ,
Tom Kirchhausen
,
Anwesha Sanyal,
Ravi Ojha ,
Jesse D. Pyle ,
Olli Vapalahti ,
Giuseppe Balistreri ,
Tom Kirchhausen
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the coronavirus disease 2019 (COVID-2019) global pandemic. There are ongoing efforts to uncover effective antiviral agents that could mitigate the severity of the disease by controlling the ensuing viral replication.